EULAR Course on Health Economics in Rheumatology
Health economics covers an important and increasing part of the assessment of burden of disease. It has become an essential discipline to estimate the benefits and costs of health care interventions, as well as to explore how therapeutic innovations can be made available to physicians and patients in our quite constraint economic environment.
The EULAR Course on Health Economics in Rheumatology aims to present the key principles of health economics applied to rheumatic or musculoskeletal disorders:
- Basic principles in health economics and health technology assessment,
- Economic burden (Cost-of illness) assessment,
- Cost-effectiveness and cost-utility analysis using model- or trial-based data for a better understanding of drug pricing.
The course will be based on interactive learning and practical training.
The participant profile for this two-day course is the following:
1) Young scientists working in the field of rheumatology or musculoskeletal diseases,
2) New or with little experience to the field of health economics;
3) Planned or ongoing involvement in a health economic project.
Young researchers attending this course will also have an opportunity to get together for future collaborations.
This course will be selective, with competitive admission: the number of attendees is limited to 40.
1st EULAR Course on Health Economics in Rheumatology
31 March – 1 April 2016 in Nancy, France
Registration is now closed.
EULAR Course Bursaries
EULAR grants 10 bursaries at EUR200.
Applications for bursaries should include:
- Curriculum vitae with date of birth
- Motivation letter
- List of publications
Please note that a bursary application can only be considered if the course application is also received and if the applicant is below the age of 40.
Application process is now closed.